Nanosphere, Inc. Announces the Closing of Common Stock Offering
October 27, 2014 16:01 ET
|
Nanosphere, Inc.
NORTHBROOK, Ill., Oct. 27, 2014 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (the "Company") (Nasdaq:NSPH), a company enhancing medicine through targeted molecular diagnostics, today announced the closing of...
Nanosphere Prices $20 Million Public Offering of Common Stock
October 22, 2014 09:00 ET
|
Nanosphere, Inc.
NORTHBROOK, Ill., Oct. 22, 2014 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (the "Company") (Nasdaq:NSPH), a leader in the development and commercialization of advanced molecular diagnostics systems, today...
Nanosphere Announces Commencement of Public Offering of Common Stock; Preliminary Third Quarter 2014 Top Line Results
October 21, 2014 16:01 ET
|
Nanosphere, Inc.
NORTHBROOK, Ill., Oct. 21, 2014 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (the "Company" or "Nanosphere") (Nasdaq:NSPH), a company enhancing medicine through targeted molecular diagnostics, today announced...
FDA Clears Additional Viral Targets on Verigene Enteric Pathogens Test
October 13, 2014 08:00 ET
|
Nanosphere, Inc.
NORTHBROOK, Ill., Oct. 13, 2014 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (Nasdaq:NSPH), a company enhancing medicine through targeted molecular diagnostics, today announced it has received 510(k)...
New Outcomes Data Presented at ICAAC 2014 Further Validates Clinical and Economic Utility of Nanosphere's Verigene Blood Culture Test
September 08, 2014 08:00 ET
|
Nanosphere, Inc.
NORTHBROOK, Ill., Sept. 8, 2014 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (Nasdaq:NSPH), a company enhancing medicine through targeted molecular diagnostics, announced that data from three outcomes studies...
Nanosphere Announces Review of Strategic Alternatives
September 04, 2014 16:01 ET
|
Nanosphere, Inc.
NORTHBROOK, Ill., Sept. 4, 2014 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (Nasdaq:NSPH), a company enhancing medicine through targeted molecular diagnostics, today announced that the Company has...
New Clinical and Economic Outcome Data for Verigene Blood Culture Test to Be Presented at ICAAC 2014
September 02, 2014 08:00 ET
|
Nanosphere, Inc.
NORTHBROOK, Ill., Sept. 2, 2014 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (Nasdaq:NSPH), a company enhancing medicine through targeted molecular diagnostics, today announced that three outcomes studies...
Nanosphere Appoints Kristopher Wood to Its Board of Directors
August 20, 2014 16:01 ET
|
Nanosphere, Inc.
NORTHBROOK, Ill., Aug. 20, 2014 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (Nasdaq:NSPH), a company enhancing medicine through targeted molecular diagnostics, today announced the appointment of Kristopher...
Nanosphere Announces Second Quarter Financial and Operating Results
August 06, 2014 16:01 ET
|
Nanosphere, Inc.
Corporate Highlights and Business Guidance:
Added 37 new Verigene® System customer placements
Achieved Q2 2014 revenues of $2.7 million, a 44% increase over Q2 2013
Increased...
Nanosphere to Release Second Quarter Results and Host Investor Conference Call on Wednesday, August 6, 2014
July 23, 2014 08:00 ET
|
Nanosphere, Inc.
NORTHBROOK, Ill., July 23, 2014 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (Nasdaq:NSPH), a company enhancing medicine through targeted molecular diagnostics, today announced that it will report its results...